Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Equipe Genetique des Anomalies du Developpement, |
RCV000755674 | SCV000883078 | uncertain significance | Pigmented nodular adrenocortical disease, primary, 2 | 2018-11-21 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001585688 | SCV001818572 | likely pathogenic | not provided | 2020-10-01 | criteria provided, single submitter | clinical testing | Reported as an ACMG secondary finding in individuals who underwent whole exome sequencing; detailed clinical information was not provided (Sapp et al., 2018; Thauvin-Robinet et al., 2019); Not observed at a significant frequency in large population cohorts (Lek et al., 2016); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 32686758, 31402444, 31019283, 30122538, 23911551) |
Invitae | RCV001855862 | SCV002129649 | pathogenic | Arrhythmogenic right ventricular dysplasia 11 | 2021-10-23 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals affected with DSC2-related conditions. This sequence change creates a premature translational stop signal (p.Arg375*) in the DSC2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DSC2 are known to be pathogenic (PMID: 23911551). This variant is present in population databases (no rsID available, gnomAD 0.003%). ClinVar contains an entry for this variant (Variation ID: 617896). For these reasons, this variant has been classified as Pathogenic. |
Ce |
RCV001585688 | SCV002822450 | likely pathogenic | not provided | 2023-04-01 | criteria provided, single submitter | clinical testing | DSC2: PVS1 |
Baylor Genetics | RCV001855862 | SCV004040851 | pathogenic | Arrhythmogenic right ventricular dysplasia 11 | 2023-04-03 | criteria provided, single submitter | clinical testing | |
Johns Hopkins Genomics, |
RCV001855862 | SCV004239085 | pathogenic | Arrhythmogenic right ventricular dysplasia 11 | 2023-08-21 | criteria provided, single submitter | clinical testing | This DSC2 variant (rs794728075) is rare (<0.1%) in a large population dataset (gnomADv2.1.1: 2/251006 total alleles; 0.0008%; no homozygotes) and has been reported in ClinVar and in the literature as a secondary finding following genomic-based testing. This nonsense variant results in a premature termination codon (PTC) in exon 9 of 16, likely leading to nonsense-mediated decay and lack of protein production. Bioinformatic analysis predicts that this missense variant would not affect normal exon 9 splicing, although this has not been confirmed experimentally to our knowledge. We consider c.1123C>T (p.Arg375Ter) to be pathogenic for arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C). |